Full-Time

Clinical Oncology Specialist

Posted on 12/16/2024

Natera

Natera

1,001-5,000 employees

Genetic testing and diagnostics solutions provider

Biotechnology
Healthcare

Compensation Overview

$185k - $225kAnnually

Senior

Tampa, FL, USA

Territory includes South Tampa, FL.

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Required Skills
Sales
Requirements
  • Bachelor’s degree and at least 5 years of Oncology experience OR associate degree and 7 years of Oncology experience.
  • Knowledge of local oncology market.
  • Knowledge of oncology molecular diagnostics and personalized medicine.
Responsibilities
  • Learn Natera products, services, processes, policies, key internal teams, as well as competitor’s products, services, policies and practices, and payer/reimbursement landscape in the territory to be effective in the COS role.
  • Identify Key Opinion Leaders (KOLs), hospitals, clinics and physicians that are appropriate for Natera products & services in the territory and gain their trust and business.
  • Calls on oncologists and other medical personnel to provide product information for the sale of Natera’s Oncology diagnostics.
  • Capitalize on selling opportunities and/or to influence physician, key opinion leaders, hospitals and clinics.
  • Responsible for the sale of the company’s oncology diagnostics products within an assigned territory or geographic region.
  • Monitor, document and report on existing business as well as challenges and new opportunities. Escalate issues not resolved timely or to the satisfaction of the clients.
  • Conduct business in an ethical & transparent fashion.
  • Perform other duties as assigned.

Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology is cell-free DNA (cfDNA) testing, which analyzes DNA fragments in the blood to detect minimal traces of cancer and assess organ health. Natera differentiates itself by offering specialized tests like the Signatera ctDNA test and Panorama NIPT for prenatal screening, along with genetic counseling services. The company's goal is to enhance patient care through accurate testing and personalized guidance.

Company Stage

IPO

Total Funding

$149.9M

Headquarters

Austin, Texas

Founded

2004

Growth & Insights
Headcount

6 month growth

9%

1 year growth

25%

2 year growth

66%
Simplify Jobs

Simplify's Take

What believers are saying

  • Increased demand for liquid biopsy techniques boosts Natera's cfDNA testing solutions.
  • Telehealth expansion aligns with Natera's remote genetic counseling services.
  • Growing personalized medicine trend enhances relevance of Natera's ctDNA tests.

What critics are saying

  • Hindenburg report alleges deceptive sales practices, risking legal challenges and reputational damage.
  • New Prospera Heart features may face slow adoption by healthcare providers.
  • Fetal RhD NIPT demand may decline post-RhIg shortage, impacting revenue.

What makes Natera unique

  • Natera's Signatera test offers personalized ctDNA analysis for cancer patients.
  • Prospera Heart test uses unique Donor Quantity Score for transplant rejection detection.
  • Fetal RhD NIPT test addresses RhIg shortage, offering early fetal RhD status detection.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible medical plans

Investment options

Time off

Workplace perks